Skip to content

Branding

INR Logo 2015

Site Message

1877 S. Federal Hwy., Suite 110
Boca Raton, FL 33432

Phone: +1 (561) 353-9707
Fax: +1 (561) 372-7874

  • Facebook
  • YouTube
  • Twitter
  • LinkedIn
  • Google Plus

Mobile Header

Institute Logo

  • Home
  • Alzheimer’s
  • REQUEST A CONSULTATION
  • Alzheimer’s Videos
  • Scientific Publications
  • Contact Info & Directions
  • About
    • About the Institute
    • Scientific Articles
    • Scientific Citations
    • Edward Tobinick Biography
    • Physician Training
    • Terms of Use
    • Privacy Policy
    • Links
  • Home
  • /
  • attachment
  • /
  • Decourt Targeting TNFa for Alzheimer’s Disease

Decourt Targeting TNFa for Alzheimer’s Disease

Posted on
October 8, 2025 by INR PLLC

Decourt Targeting TNFa for Alzheimer's Disease

This entry was posted in . Bookmark the permalink.

Post navigation

← Scientific Publications

About the Institute

In 2003 the INR published the first of its many peer-reviewed scientific publications documenting the INR's medical breakthroughs in the field of neuroinflammation. Since that time scientists around the world have developed supporting evidence that suggests, in accordance with the findings of INR physicians, that dormant circuits in the brain and other parts of the central nervous system, following stroke and other forms of injury, are capable of being re-activated, resulting in rapid neurological improvement. The INR's breakthrough treatment is not experimental: it has been used for thousands of patients, from every populated continent in the world, including from the U.S., Canada, England, Scotland, Wales, Ireland, Mexico, Trinidad, Jamaica, Haiti, Bahamas, Guatemala, Belize, Brazil, Columbia, Bolivia, Uruguay, Ecuador, Chile, Peru, Germany, France, Spain, Italy, Portugal, Belgium, Netherlands, Switzerland, Bulgaria, Romania, Ukraine, Poland, Denmark, Sweden, Norway, Iceland, Gibraltar, Uzbekistan, Turkey, Israel, Saudi Arabia, UAE, Oman, Iraq, Egypt, Morocco, Nigeria, Ghana, Cameroon, South Africa, Mozambique, Kenya, Mauritius, India, Bangladesh, Thailand, Vietnam, China, Hong Kong, Japan, Indonesia, Malaysia, Philippines, Australia, New Zealand, Papua New Guinea, Fiji, and the Cook Islands.

Hundreds of scientific articles from academic scientists have cited INR publications. In addition to patient care, the INR has trained physicians from six continents in the proper implementation of its patented, off-label perispinal etanercept treatment methods.

The INR's issued and pending U.S. and foreign patents, include, but are not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8,900,583; Australian patents 758523 and 2011323616 B2, Canadian patent 2,811,948, European patent ES2620749 (T3), etc., all assigned to TACT IP LLC.

Connect With Us

Institute of Neurological Recovery
INR PLLC
1877 S. Federal Hwy., Suite 110
Boca Raton, FL 33432
Phone: +1 (561) 353-9707
Fax: +1 (561) 372-7874
E-mail: INRBoca@gmail.com

  • Facebook
  • YouTube
  • Twitter
  • LinkedIn
  • Google Plus

Quick Links

  • Home
  • REQUEST A CONSULTATION
  • VIDEOS
  • Blog
  • About
  • Terms of Use
  • Privacy Policy

About the Institute

Institute of Neurological Recovery
1877 S. Federal Hwy.
Suite 110
Boca Raton, FL 33432
Phone: +1 (561) 353-9707

The Institute of Neurological Recovery® (INR®). A decade of pioneering discoveries in medicine. The INR utilizes the pioneering, patented perispinal etanercept (PSE) off-label treatment methods invented by its founder and Medical Director, Edward Tobinick, M.D. The contents of this website, including text, images, and videos are ©2020 INR PLLC, all rights reserved.

  • Facebook
  • YouTube
  • Twitter
  • LinkedIn
  • Google Plus

  • Call
  • REQUEST A CONSULTATION
  • Directions

© Copyright 2010-2025 Institute of Neurological Recovery All Rights Reserved.

Website Design & Development by Altra Web Design